55513-924 : Neupogen 300 ug/.5ml Intravenous; Subcutaneous Injection, Solution


NDC55513-924
Labeler: Amgen Inc
Product Type: Human Prescription Drug
Drug Name:  Neupogen
Dosage Form: Intravenous; Subcutaneous Injection, Solution
Application #: BLA103353
Rev. Date: 


NDC Package Codes:

  • 55513-924-10: 10 SYRINGE IN 1 BOX (55513‑924‑10) > .5 ML IN 1 SYRINGE (55513‑924‑01)
  • 55513-924-91: .5 ML IN 1 SYRINGE (55513‑924‑91)

Active Ingredients:

  • Filgrastim

Dosage Strength:

  • 300 ug/.5mL

Pharmaceutical Classes:

  • Granulocyte Colony-Stimulating Factor [CS]
  • Granulocyte-Macrophage Colony-Stimulating Factor [CS]
  • Increased Myeloid Cell Production [PE]
  • Leukocyte Growth Factor [EPC]

Related Products:

Based on records with the same trade name.
  • 55513-209 Neupogen 480 ug/.8ml Intravenous; Subcutaneous Injection, Solution by Amgen Inc
  • 55513-530 Neupogen 300 ug/ml Intravenous; Subcutaneous Injection, Solution by Amgen Inc
  • 55513-546 Neupogen 480 ug/1.6ml Intravenous; Subcutaneous Injection, Solution by Amgen Inc
  • 54868-2522 Neupogen 300 ug/ml Intravenous Injection, Solution by Physicians Total Care, Inc.
  • 54868-3050 Neupogen 480 ug/.8ml Intravenous Injection, Solution by Physicians Total Care, Inc.
  • 54868-5020 Neupogen 300 ug/.5ml Intravenous Injection, Solution by Physicians Total Care, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 55513-924 QR Code

< Prev: 55513-880Next: 55513-954 >

Related Discussions:

side effects,neupogen
stimulates white blood cells...




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA